<- Go Home

NeurAxis, Inc.

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8 years of age with functional abdominal pain associated with irritable bowel syndrome (IBS), functional dyspepsia (FD) and associated FD nausea symptoms. The company also offers rectal expulsion device, a screening tool that helps to detects evacuation disorders. It sells its products to healthcare companies, such as hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. NeurAxis, Inc. was founded in 2011 and is headquartered in Carmel, Indiana.

Market Cap

$95.1M

Volume

622.0K

Cash and Equivalents

$7.1M

EBITDA

-$6.6M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$3.6M

Profit Margin

85.01%

52 Week High

$9.33

52 Week Low

$2.07

Dividend

N/A

Price / Book Value

16.49

Price / Earnings

-10.13

Price / Tangible Book Value

17.29

Enterprise Value

$88.4M

Enterprise Value / EBITDA

-13.66

Operating Income

-$6.6M

Return on Equity

242.53%

Return on Assets

-70.54

Cash and Short Term Investments

$7.1M

Debt

$353.5K

Equity

$5.7M

Revenue

$4.3M

Unlevered FCF

-$3.4M

Sector

Health Care Equipment and Supplies

Category

N/A

Company Stock Pitches